389 related articles for article (PubMed ID: 31223391)
1. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
[TBL] [Abstract][Full Text] [Related]
2. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
[TBL] [Abstract][Full Text] [Related]
3. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
Tavakolpour S
Int Immunopharmacol; 2017 Dec; 53():133-142. PubMed ID: 29107213
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
5. Pemphigus vulgaris: approach to treatment.
Sinha AA; Hoffman MB; Janicke EC
Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
[TBL] [Abstract][Full Text] [Related]
6. Blisters in disguise.
Dowlatshahi EA; Diercks G; van Doorn M
BMJ; 2018 Jan; 360():j5364. PubMed ID: 29301743
[No Abstract] [Full Text] [Related]
7. [Pemphigus: current and future treatment strategies].
Kussini J; Kaisers T; Sequeira Santos AM; Eming R; Didona D
Dermatologie (Heidelb); 2022 Dec; 74(12):915-926. PubMed ID: 37902884
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients.
Brown AE; Motaparthi K; Hsu S
Dermatol Online J; 2018 Jan; 23(12):. PubMed ID: 29447653
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
[TBL] [Abstract][Full Text] [Related]
10. The adjuvant therapy of pemphigus. An update.
Bystryn JC; Steinman NM
Arch Dermatol; 1996 Feb; 132(2):203-12. PubMed ID: 8629830
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of pemphigus vegetans by addition of etretinate to systemic steroids.
Ichimiya M; Yamamoto K; Muto M
Clin Exp Dermatol; 1998 Jul; 23(4):178-80. PubMed ID: 9894363
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.
Zhao W; Wang J; Zhu H; Pan M
Clin Rev Allergy Immunol; 2021 Dec; 61(3):351-362. PubMed ID: 34350539
[TBL] [Abstract][Full Text] [Related]
14. [Neumann type pemphigus vegetans with fatal outcome].
Näher H
Hautarzt; 1993 Feb; 44(2):99-102. PubMed ID: 8449702
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
[TBL] [Abstract][Full Text] [Related]
16. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus.
Shaik F; Botha J; Aboobaker J; Mosam A
Clin Exp Dermatol; 2010 Apr; 35(3):245-50. PubMed ID: 19874327
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pemphigus in Australia: Aligning current practises with global recommendations.
Somerville E; Gebauer K; Mclean-Tooke A
Australas J Dermatol; 2022 May; 63(2):190-196. PubMed ID: 35184283
[TBL] [Abstract][Full Text] [Related]
19. Nasal, pharyngeal, and laryngeal pemphigus vulgaris successfully treated with rituximab.
Sami N
Ear Nose Throat J; 2017; 96(4-5):E35-E38. PubMed ID: 28489243
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
Baum S; Gilboa S; Greenberger S; Pavlotsky F; Trau H; Barzilai A
J Dermatolog Treat; 2013 Dec; 24(6):427-30. PubMed ID: 23521340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]